bullish
Wuxi Biologics Placement: Almost All of the past Deals Have Done Well, Would Bid near the Bottom End
491 Views09 Jan 2020 18:14
Wuxi Biologics Holdings is looking to raise upto US$672m by selling 4.2% of Wuxi Biologics (Cayman) Inc (2269 HK). This will be seventh placement...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (26 Jan 2020) - Central Retail Corp, Smoore, Mindspace Biz Parks REIT, Elite Comm REIT26 Jan 2020
- ECM Weekly (19 Jan 2020) - Mr. DIY, UTI AMC, Sinopharm, Sunac, Jinxin, China Lit19 Jan 2020
- ECM Weekly (12 Jan 2020) - Jiumaojiu, I-Mab, Phoenix Tree, Burger King India12 Jan 2020
- Wuxi Biologics Placement: A Larger Deal but Performance Track Record Weighs31 Oct 2019
- Wuxi Biologics Placement: Past Deal Did Well Despite Sell-Down Overhang18 Jun 2019
- ECM Weekly (23 March 2019) - ESR, Sun Car, Ruhnn, CanSino, Frontage, Wuxi Bio, WiseTech,23 Mar 2019
x